Neuilly-Sur-Seine

France

54 total trials 23 recruiting

Filter these 54 trials by phase, condition, sponsor and more.

Open in Search →

ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Ended

2022-500536-11-01 5 2023-06-08 Moderately to severely active ulcerative colitis
A multi-center study to evaluate the safety, tolerability and efficacy of TIN816 in patients at risk for acute kidney injury following a car … Ended

2024-511621-64-00 4 2023-01-18 Acute kidney injury
SENS-401 to Prevent the Ototoxicity induced by Cisplatin in Adult Subjects with a Neoplastic Disease Ended

2024-511713-38-00 4 2022-12-30 Cisplatine induced hearing loss
The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic … Ended

2024-517251-12-00 5 2021-11-02 Recurrent or metastatic head and neck squamous cell carcinoma
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn's Disease Ended

2024-511553-22-00 5 2018-10-05 Moderately to Severely Active Crohn's Disease
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn's Disease Ended

2023-510426-33-00 5 2018-09-27 Moderately to Severely Active Crohn's Disease

Showing 49–54 of 54 trials